<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01225809</url>
  </required_header>
  <id_info>
    <org_study_id>AFF003E</org_study_id>
    <nct_id>NCT01225809</nct_id>
  </id_info>
  <brief_title>AD01 Follow up Extension Visit</brief_title>
  <official_title>Observational Follow-up Extension Study-visit to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD01 Applied During AFFiRiS001 in Patients With Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Affiris AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Affiris AG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who were vaccinated with AFFITOPE AD01 during AFFiRiS001 will undergo a long-term
      follow-up period to get more information regarding the safety profile of AFFITOPE AD01.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Long term tolerability and safety of AFFITOPE AD01</measure>
    <time_frame>One year.</time_frame>
    <description>retrospective assessment of safety data</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">17</enrollment>
  <condition>Alzheimer´s Disease</condition>
  <arm_group>
    <arm_group_label>AD01with or without adjuvant</arm_group_label>
    <description>Patients who have received at least one immunization of AD01 with or without adjuvant during AFF001</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients having participated in AFFiRiS 001 and AFF003 and having received ≥1 vaccination
        with AFFITOPE AD01
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent signed and dated by the patient or the patient's legal
             representative and the caregiver.

          -  Patients having participated in AFFiRiS 001 and AFF003 and having received ≥1
             vaccination with AFFITOPE AD01

          -  Availability of a partner/caregiver knowing the patient

        Exclusion Criteria:

          -  Patients having received no vaccination with AFFITOPE AD01

          -  History of questionable compliance to visit schedule
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Dal-Bianco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univ. Klinik für Neurologie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Univ. Klinik für Neurologie</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2010</study_first_submitted>
  <study_first_submitted_qc>October 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2010</study_first_posted>
  <last_update_submitted>January 25, 2011</last_update_submitted>
  <last_update_submitted_qc>January 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2011</last_update_posted>
  <responsible_party>
    <name_title>Achim Schneeberger; CMO</name_title>
    <organization>AFFiRiS AG</organization>
  </responsible_party>
  <keyword>AD01 follow-up extension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

